Cargando…

MiR-4291 stabilized the vulnerable atherosclerotic plaques by degrading the MAPK1/ERK2 in ApoE(-/-) mice

BACKGROUND: This study sought to explore the mechanism of action of the micro ribonucleic acid (miR)-4291 in stabilizing atherosclerotic (AS) plaques. METHODS: An AS model of apolipoprotein E-deficient (ApoE(-/-)) mice fed a high-fat diet (HFD) was established. Oxidized low-density lipoprotein (ox-L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yaqiong, Lu, Jingchao, Liu, Fan, Yang, Xiuchun, Chen, Fei, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761127/ https://www.ncbi.nlm.nih.gov/pubmed/36544668 http://dx.doi.org/10.21037/atm-22-5241

Ejemplares similares

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice
por: Chen, Junwen, et al.
Publicado: (2014)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
por: Leipner, Julia, et al.
Publicado: (2021)

Overexpression of TGF-ß1 in Macrophages Reduces and Stabilizes Atherosclerotic Plaques in ApoE-Deficient Mice
por: Reifenberg, Kurt, et al.
Publicado: (2012)

4291 Quantifying the art of surgical decision-making in total knee arthroplasty
por: Elmasry, Shady, et al.
Publicado: (2020)

Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties
por: Wang, Shuang-shuang, et al.
Publicado: (2015)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Tryptase Promotes Atherosclerotic Plaque Haemorrhage in ApoE-/- Mice
por: Zhi, Xiuling, et al.
Publicado: (2013)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

The Complementary Effects of Atorvastatin and Exercise Treatment on the Composition and Stability of the Atherosclerotic Plaques in ApoE Knockout Mice
por: Moustardas, Petros, et al.
Publicado: (2014)

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering
por: Ramms, Bastian, et al.
Publicado: (2022)

Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
por: Gargiulo, Sara, et al.
Publicado: (2016)

Atherosclerotic plaque vulnerability is increased in mouse model of lupus
por: Santiago-Raber, Marie-Laure, et al.
Publicado: (2020)

BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
por: Alloza, Iraide, et al.
Publicado: (2020)

Overexpressed miR‐335‐5p reduces atherosclerotic vulnerable plaque formation in acute coronary syndrome
por: Sun, Dingjun, et al.
Publicado: (2020)

Circular RNA circLMO1 Suppresses Cervical Cancer Growth and Metastasis by Triggering miR-4291/ACSL4-Mediated Ferroptosis
por: Ou, Rongying, et al.
Publicado: (2022)

Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability
por: Ruddy, Jean Marie, et al.
Publicado: (2016)

CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE(−/−) mice
por: Zhang, Zhongwen, et al.
Publicado: (2015)

Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe (−/−) mice with hyperhomocysteinemia
por: Li, Hongjun, et al.
Publicado: (2016)

Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability
por: Hutcheson, Joshua D., et al.
Publicado: (2014)

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques
por: Horvath, Martin, et al.
Publicado: (2016)

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques
por: Fumagalli, Stefano, et al.
Publicado: (2017)

Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021)

Vulnerable atherosclerotic plaque features: findings from coronary imaging
por: Kurihara, Osamu, et al.
Publicado: (2021)

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
por: Zhang, Ming, et al.
Publicado: (2022)

Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

cGAS-STING Pathway Performance in the Vulnerable Atherosclerotic Plaque
por: Wan, Xueqi, et al.
Publicado: (2022)

Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability
por: Zhang, Ge, et al.
Publicado: (2023)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

Capsanthin Inhibits Atherosclerotic Plaque Formation and Vascular Inflammation in ApoE(−/−) Mice
por: Kim, Sungmin, et al.
Publicado: (2022)

Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability
por: Chen, Zhu, et al.
Publicado: (2010)

Bionic Microbubble Neutrophil Composite for Inflammation-Responsive Atherosclerotic Vulnerable Plaque Pluripotent Intervention
por: Liu, Fangfang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7mtr1oabfhhc9e5m7sp7rf2bb4